Best The Pmc 2025 Podcasts (2025)

1
Immunotherapy Safety for Hepatocellular Carcinoma in Latin America: Insights from a Real-World Study 4:27

3d ago4:27

4:27

Liver cancer, especially hepatocellular carcinoma (HCC), remains a major health concern worldwide. In Latin America, the situation becomes more difficult due to limited access to advanced treatments and the high prevalence of underlying liver diseases. A recent research paper, published in Volume 16 of Oncotarget by researchers from Argentina, Braz…

1
New Drug Combination Redefines First-Line Treatment for Advanced Urothelial Cancer 3:38

4d ago3:38

3:38

BUFFALO, NY – July 1, 2025 – A new #review was #published in Volume 16 of Oncotarget on June 17, 2025, titled “Optimizing enfortumab vedotin plus pembrolizumab therapy.”First authors Elias Antoine Karam of the Gustave Roussy and Saint-Joseph University of Beirut and Yaghi César Céline from the Saint-Joseph University of Beirut, along with their col…

1
From Reactive to Proactive: Anna Pengally on AI, Data & the Future of Maintenance with Tapi 36:08

5d ago36:08

36:08

In this episode of The Alternative Property Management Show, powered by Renti and brought to you by The PMC, we sit down with Anna Pengally from proptech maintenance powerhouse Tapi. Anna shares Tapi’s journey and what brings her to New Zealand, diving deep into how artificial intelligence and big data are revolutionising maintenance in property ma…

1
Divinely Disabled

7d ago

—

Divinely DisabledBy Jacob Gibbs

1
HER2-Mutated NSCLC in Brazil Shows Diverse Genetic Patterns and Treatment Gaps 4:35

8d ago4:35

4:35

BUFFALO, NY – June 27, 2025 – A new #research paper was #published in Volume 16 of Oncotarget on June 17, 2025, titled “Molecular landscape of HER2-mutated non-small cell lung cancer in Northeastern Brazil: Clinical, histopathological, and genomic insights.”In this study, researchers led by first authors Cleto Dantas Nogueira from the Federal Unive…

1
WIN International Molecular Tumor Board Recommends Tailored Treatment for Advanced Colorectal Cancer 4:40

11d ago4:40

4:40

BUFFALO, NY – June 24, 2025 – A new precision #oncology paper was #published in Volume 16 of Oncotarget on June 17, 2025, titled “Case Report WIN-MTB-2023001 WIN International Molecular Tumor Board A 62-year-old male with metastatic colorectal cancer with 5 prior lines of treatment.”In this report, led by Alberto Hernando-Calvo from Vall d’Hebron U…

1
Chasing the Wind

14d ago

—

Chasing the WindBy John Glass

1
CHEK2 Identified as a Potential Target to Improve Immunotherapy in Solid Tumors 4:34

15d ago4:34

4:34

BUFFALO, NY – June 20, 2025 – A new #review was #published in Volume 16 of Oncotarget on June 10, 2025, titled “Beyond DNA damage response: Immunomodulatory attributes of CHEK2 in solid tumors.”In this paper, led by first author Helen Qian and corresponding author Crismita Dmello from Northwestern University Feinberg School of Medicine, researchers…

1
From the Ground Up: Kay Glendining on Building, Balance & Bayleys 38:11

16d ago38:11

38:11

In this episode of The Alternative Property Management Show, powered by Renti and brought to you by The PMC 2025, we sit down with Kay Glendining from Bayleys St Heliers. Having learned from some of the best in the business — including Megan Jaffe at Ray White Remuera — Kay shares her journey of growing a rent roll from scratch to over 100 properti…

1
Rare Pancreatic Cancer Patients Show Strong Response to Immunotherapy 3:53

18d ago3:53

3:53

BUFFALO, NY - June 17, 2025 – A new #research paper was #published in Volume 16 of Oncotarget on June 10, 2025, titled “Exceptional responders to immunotherapy in pancreatic cancer: A multi-institutional case series of a rare occurrence.”The study, led by first author Kavin Sugumar and corresponding author Jordan M. Winter, from University Hospital…

1
Exploring a Combined Approach: Radiation and Immunotherapy in Bladder Cancer 6:56

19d ago6:56

6:56

Bladder cancer remains a significant clinical concern, with more than 85,000 new diagnoses and nearly 19,000 deaths reported annually in the United States. While current treatments like surgery, chemotherapy, and radiation can be effective for early-stage disease, many patients with advanced or recurrent cancer face limited options.A recent review,…

1
Lessons From the Kings

21d ago

—

Lessons From the KingsBy John Glass

1
Balancing Time, Cost, and Quality in Cardio-Oncology Care 3:21

22d ago3:21

3:21

BUFFALO, NY - June 13, 2025 – A new #review was #published in Volume 16 of Oncotarget on June 4, 2025, titled “Applying the unattainable triangle in cardio-oncology care: Balancing cost, quality, and time.”In this review, first author John Hoverson, corresponding author Stella Pak, and colleagues from the University of Texas Health Science Center a…

1
Rare Non-Small Cell Lung Cancer with Brain Metastases Responds to Amivantamab Monotherapy 4:03

24d ago4:03

4:03

BUFFALO, NY - June 11, 2025 – A new #research paper was #published in Volume 16 of Oncotarget on May 29, 2025, titled “Durable complete response in leptomeningeal disease of EGFR mutated non-small cell lung cancer to amivantamab, an EGFR-MET receptor bispecific antibody, after progressing on osimertinib.”A team led by first author Jinah Kim, from t…

1
Politics, Property & Policy: A Deep Dive with Matt Ball from NZPIF 43:04

24d ago43:04

43:04

In the latest episode of The Alternative Property Management Show, powered by Renti and in conjunction with The PMC 2025, we’re joined by Matt Ball — Advocacy Manager for the New Zealand Property Investors Federation and self-confessed political tragic. Matt shares insights from his extensive work in Wellington, where he lobbies across the politica…

1
Oncotarget Sponsors Open Access Team in 2025 Ride for Roswell 2:45

25d ago2:45

2:45

BUFFALO, NY — June 10, 2025 — The Ride for Roswell, one of the USA’s largest cycling events supporting cancer research, returns to Buffalo on Saturday, June 28, 2025. Hosted annually by Roswell Park Comprehensive Cancer Center, this community-wide event brings together riders, volunteers, and supporters to raise funds for cancer research, celebrate…

1
Cigarette Smoke and DNA Repair Deficiency Drive Lung Cancer Development 3:35

26d ago3:35

3:35

BUFFALO, NY – June 9, 2025 – A new #research paper was #published in Volume 16 of Oncotarget on May 20, 2025, titled “Cigarette smoke and decreased DNA repair by Xeroderma Pigmentosum Group C use a double hit mechanism for epithelial cell lung carcinogenesis.”In this study, led by first author Nawar Al Nasralla and corresponding author Catherine R.…

1
Why the Best Take a Rest

28d ago

—

Why the Best Take a RestBy Shane Anderson

1
Law, Logic & a Little Humanity: Sarina Gibbon on Changing the PM Conversation 42:05

1M ago42:05

42:05

In this episode of The Alternative Property Management Show, the boys are joined by legal eagle and all-round top lady Sarina Gibbon — General Manager of the Auckland Property Investors Association and founder of Tenancy Advisory Ltd. Sarina shares her journey from law school to becoming one of the most influential voices in New Zealand's rental se…

1
Experimental Triple Therapy Improves Survival in Glioblastoma Mouse Model 5:38

1M ago5:38

5:38

Researchers at Brown University have developed a combination treatment that significantly increases survival in mice with glioblastoma (GBM), a highly aggressive and treatment-resistant brain cancer. The approach uses a new class of drugs called imipridones along with radiation therapy and standard chemotherapy. This triple therapy, known as IRT, w…

1
Targeting PCNA-Androgen Receptor Interaction Suppresses Prostate Cancer Cell Growth 3:55

1M ago3:55

3:55

BUFFALO, NY - June 4, 2025 – A new #research paper was #published in Volume 16 of Oncotarget on May 20, 2025, titled “Targeting PCNA/AR interaction inhibits AR-mediated signaling in castration resistant prostate cancer cells."In this study, authors Shan Lu and Zhongyun Dong from the University of Cincinnati College of Medicine investigated how inte…

1
Blocking PRDX1 Protein May Improve Chemotherapy Response in Ovarian Cancer 4:10

1M ago4:10

4:10

BUFFALO, NY - June 3, 2025 – A new #research paper was #published in Volume 16 of Oncotarget on May 19, 2025, titled “PRDX1 protects ATM from arsenite-induced proteotoxicity and maintains its stability during DNA damage signaling."In this study, led by first author Reem Ali and corresponding author Dindial Ramotar from Hamad Bin Khalifa University …

1
Part 7: And Then, the End Will Come

1M ago

—

Part 7: And Then, the End Will ComeBy Shane Anderson

1
Leading with Love: Sharon Bradley on Emotional Intelligence in Property Management 35:55

1M ago35:55

35:55

This week, with Harrison Vaughan mysteriously missing in action after a week-long bender at AREC 2025, David Faulkner and Will Alexander are holding down the fort. But don't worry—joining them is someone who brings decades of experience, insight, and heart to the conversation. We're thrilled to welcome Sharon Bradley, founder of Transform and Thriv…

1
Ruth Murdoch Elementary Dedication & Andrews Academy 2025 Baccalaureate

1M ago

—

Ruth Murdoch Elementary Dedication & Andrews Academy 2025 BaccalaureateBy Special Program

1
Immune Side Effects of Liver Cancer Therapy Studied in Latin American Patients 4:16

1M ago4:16

4:16

BUFFALO, NY - May 23, 2025 – A new #research paper was #published in Volume 16 of Oncotarget on May 19, 2025, titled “Immune-mediated adverse events following atezolizumab and bevacizumab in a multinational Latin American cohort of unresectable hepatocellular carcinoma."The study, led by first authors Leonardo Gomes da Fonseca from Hospital das Clí…

1
Engineered Proteins Show Promise in Stopping Glioblastoma Invasion 4:52

1M ago4:52

4:52

Scientists have engineered small, targeted proteins that can penetrate brain cancer cells and prevent them from invading healthy tissue, offering a promising new approach to treating glioblastoma multiforme (GBM), one of the deadliest forms of brain cancer. This strategy was developed by researchers at the University of Nevada, Reno, and published …

1
Combining Radiation and Immunotherapy Shows Promise for Bladder Cancer 3:45

2M ago3:45

3:45

BUFFALO, NY - May 21, 2025 – A new #review was #published in Volume 16 of Oncotarget on May 19, 2025, titled “Advancements in bladder cancer treatment: The synergy of radiation and immunotherapy."Researchers from the University of California, Irvine, led by Nazmul Hasan, reviewed recent clinical and scientific advances in combining radiation therap…

1
Boutique Beats Bulk | The Property Management Revolution with Rob Harper of Wendell Property 42:17

2M ago42:17

42:17

🎙️ This week on The Alternative Property Management Show, we are joined by Growth Panelist at The PMC | Property Management Conference 2025, Rob Harper from Wendell Property. Once again, a big shout out to our sponsor Renti who help put this together 👏 👏By The PMC 2025

1
New Ultra-Sensitive DNA Blood Test for Detecting Residual Cancer in B-cell Lymphoma Patients 4:08

2M ago4:08

4:08

BUFFALO, NY – May 19, 2025 – A new #research paper was #published in Volume 16 of Oncotarget on May 9, 2025, titled “Analytical validation of a circulating tumor DNA assay using PhasED-Seq technology for detecting residual disease in B-cell malignancies.”In this study, a team from Foresight Diagnostics led by first author Nina Klimova and correspon…

1
He’s Closer Than You Think

2M ago

—

He’s Closer Than You ThinkBy Lindsey Pratt

1
Blood Type A Identified as Potential Breast Cancer Risk Factor 3:19

2M ago3:19

3:19

BUFFALO, NY - May 14, 2025 – A new #review paper was #published in Volume 16 of Oncotarget on May 9, 2025, titled “Relationship between ABO blood group antigens and Rh factor with breast cancer: A systematic review and meta-analysis."A comprehensive study, led by first authors Rahaf Alchazal from Yarmouk University and Khaled J. Zaitoun from Johns …

1
What's really going on in the rental market? With Drake Farmer, COO of Renti 40:12

2M ago40:12

40:12

🎙️ Welcome to another unmissable episode of The Alternative Property Management Show — powered by the legends at Renti! This week, we’re turning up the heat with none other than Drake Farmer, COO of Renti and one of the sharpest minds in proptech. Drake joins the boys to unpack what’s really going on in a rental market that’s starting to shift — ye…

1
Drake Farmer, COO of Renti. What's really going on in the rental market? 40:12

2M ago40:12

40:12

🎙️ Welcome to another unmissable episode of The Alternative Property Management Show — powered by the legends at Renti! This week, we’re turning up the heat with none other than Drake Farmer, COO of Renti and one of the sharpest minds in proptech. Drake joins the boys to unpack what’s really going on in a rental market that’s starting to shift — ye…

1
Part 6: Think Small

2M ago

—

Part 6: Think SmallBy Shane Anderson

1
METTL3 Drives Oral Cancer by Blocking Tumor-Suppressing Gene 3:37

2M ago3:37

3:37

BUFFALO, NY - May 9, 2025 – A new #research paper was #published in Oncotarget, Volume 16, on May 8, 2025, titled “METTL3 promotes oral squamous cell carcinoma by regulating miR-146a-5p/SMAD4 axis."In this study, researchers Jayasree Peroth Jayaprakash, Pragati Karemore, and Piyush Khandelia from the Birla Institute of Technology and Science, India…

1
What happens when MBIE audit your business? 39:38

2M ago39:38

39:38

Welcome to the second episode of The Alternative Property Management Show, brought to you by The PMC and proudly powered by Renti 🎤🎧. In this episode, our own Harrison Vaughan from Tommy’s Property Management shares his experience and insights from his recent MBIE audit—what went well, what surprised him, and what others can learn. We also dive int…

1
Panitumumab & Low-Dose Capecitabine: Promising Maintenance Therapy for Metastatic Colorectal Cancer 6:48

2M ago6:48

6:48

A recent #study from Assiut University Hospital in Egypt, published in #Oncotarget, presents a promising strategy for patients with metastatic #colorectalcancer (mCRC). The #research introduces a gentler yet effective maintenance therapy that may extend survival, enhance quality of life, and offer a more accessible treatment option for mCRC patient…

1
Oncotarget Participation at SSP 2025 Annual Meeting 1:37

2M ago1:37

1:37

BUFFALO, NY - May 5, 2025 – Oncotarget, #published by Impact Journals, is proud to #announce its presence as an #exhibitor at the 47th Annual Meeting of the Society for Scholarly Publishing (SSP), taking place May 28–30, 2025, at the Hilton Baltimore in Maryland. Impact Journals publishes scholarly journals in the biomedical sciences, with a focus …

1
AU Baccalaureate 2025

2M ago

—

AU Baccalaureate 2025By Ivan Williams

1
A changing landscape in the rental market that now favours the tenant 35:15

2M ago35:15

35:15

🎙️ Welcome to the first episode of the latest series of The Alternative Property Management Show, proudly brought to you by The PMC and Renti. We dive into the real issues shaping the property management industry with zero spin, plenty of laughs, and a healthy dose of footy talk on the side. In this opening episode, your hosts David Faulkner, Will …

1
Early Immune Evasion Found in HPV-Related Pre-Cancer Lesions of the Anogenital Region 4:28

2M ago4:28

4:28

BUFFALO, NY - April 28, 2025 – A new #research paper was #published in Oncotarget, Volume 16, on April 24, 2025, titled “PD-L1 and FOXP3 expression in high-grade squamous intraepithelial lesions of the anogenital region."Researchers Humberto Carvalho Carneiro, Rodrigo de Andrade Natal, José Vassallo and Fernando Augusto Soares from the Instituto D’…

1
Part 5: A Taste of Heaven

2M ago

—

Part 5: A Taste of HeavenBy Shane Anderson

1
New Insights into p53: A Powerful Gene’s Role in Cancer Therapy 7:01

2M ago7:01

7:01

A new study from the Sidney Kimmel Comprehensive Cancer Center and Johns Hopkins University School of Medicine, published in Oncotarget, reveals that the gene p53, long known as the “guardian of the genome,” may be even more powerful than previously thought. By studying it in non-cancerous human cells, researchers discovered how p53 stops risky cel…

1
Part 4: One Final Revolution

3M ago

—

Part 4: One Final RevolutionBy Shane Anderson

1
Gene Variant Linked to Benign Prostate Hyperplasia Risk in Lebanese Men 4:41

3M ago4:41

4:41

BUFFALO, NY - April 15, 2025 – A new #research paper was #published in Oncotarget, Volume 16, on April 4, 2025, titled “Association between two single nucleotide polymorphisms of the Prostaglandin-Endoperoxide Synthase 1 and 2 genes and cell proliferative prostatic diseases in Lebanon."The team of researchers led by first author Brock J. Sheehan an…

1
Part 3: Ministers Rule

3M ago

—

Part 3: Ministers RuleBy Shane Anderson

1
Protein GSK3β Offers New Angle on Overcoming Melanoma Drug Resistance 3:59

3M ago3:59

3:59

BUFFALO, NY - April 11, 2025 – A new research perspective was published in Oncotarget, Volume 16, on April 4, 2025, titled “GSK3β activation is a key driver of resistance to Raf inhibition in BRAF mutant melanoma cells."In this work, first author Diana Crisan and corresponding author Abhijit Basu from the University Hospital Ulm led a team that pre…

1
Targeting SETDB1: A New Strategy for Treating Osteosarcoma 6:12

3M ago6:12

6:12

Despite decades of research, treatment for osteosarcoma has remained largely unchanged, especially for patients whose cancer spreads or returns. However, a growing body of evidence, summarized in the review “SETDB1 amplification in osteosarcomas: Insights from its role in healthy tissues and other cancer types,” published in Oncotarget, highlights …

1
Pentecost 2025

3M ago

—

Pentecost 2025By Mark Finley

Podcasts Worth a Listen

The Pmc 2025 Podcasts

Podcasts Worth a Listen

Quick Reference Guide